Arterial venous abnormalities within the lung range from very small lesions resembling spider naevi, such as those in the hepatopulmonary syndrome, to large complex abnormalities. These are virtually all congenital, although there is a small group ofacquired lesions. It is the congenital pulmonary arteriovenous malformations that are addressed in the paper by Haitjema and colleagues on pages 719-723 of this issue of Thorax.' Pulmonary arteriovenous malformations are uncommon and are often associated with hereditary haemorrhagic telangectasia. In one series2 88% of the cases of pulmonary arteriovenous malformation had haemorrhagic telangectasia, but the more generally quoted figure is around 50%.
The most common symptom is breathlessness, although this may only be elicited on direct questioning. Haemo untreated . This has been correlated with a pulmonary arteriovenous malformation feeding artery of more than 3 mm. At this level it is generally accepted that pulmonary arteriovenous malformations should be treated, although in 1991 RemyJardin et al6 described two patients with pulmonary arteriovenous malformations with "non-dilated feeding arteries" requiring surgical treatment for repeated brain abscesses.
This paper by Haitiema et al reinforces the low morbidity of embolisation. The most common complaint is of self limiting pleurisy which is felt to be due to infarction of lung distal to the coil. Changes may be seen both on chest radiography and follow up CT scanning. Late effusion may also occur. Reviewing the largest series from Haitjema, White,' Remy-Jardin,6 and Jackson,7 coil or balloon migration into the systemic circulation was potentially the most serious complication, although there were no serious sequelae except those described in this current paper which were felt to be associated with retrieval of the coil.
The critical part of embolisation is being able to obtain a stable catheter position in the feeding vessel of the pulmonary arteriovenous malformation. Embolisation should be as close to the neck of the arteriovenous communication as possible. The enlarged feeding arteries to these arteriovenous malformations often appear to have no side branches supplying the parenchyma while the shunt is present, but this is simply due to a steal phenomenon and almost invariably multiple small side branches which only fill after the occlusion of the shunt would be present. A coil position at the neck of the pulmonary arteriovenous malformation preserves these more proximal branches and prevents unnecessary lung infarction. Embolisation is more straightforward if the pulmonary arteriovenous malformation has a single feeding vessel (simple pulmonary arteriovenous malformation) rather than a complex pulmonary arteriovenous malformation with more than one feeding vessel. In the paper by Haitjema et A surgical review by Puskas et al8 which documented 21 patients collected over 28 years emphasises the relative rarity of these lesions. In the early years eight of these had no treatment, four were lost to follow up, and one was only recognised just before death due to heart failure. The three who were followed long term all had strokes, two at a relatively young age and one also had a brain abscess at another time. Nine patients had surgical resection without mortality or significant morbidity, and in one of these patients the surgery was performed after recanalisation following previous balloon embolotherapy. There was no documented recurrence of pulmonary arteriovenous malformation in any of these patients in a median follow up period of 12 years. In this paper the surgical results were compared with five patients undergoing balloon embolotherapy who had distinctly poor results. This comparison led to the unequivocal statement that surgery should be the treatment of choice. Such a conclusion would not be valid when compared with the morbidity and mortality 
